
- /
- Supported exchanges
- / US
- / THRM.NASDAQ
Gentherm Inc (THRM NASDAQ) stock market data APIs
Gentherm Inc Financial Data Overview
Gentherm Incorporated designs, develops, manufactures, and sells thermal management and pneumatic comfort technologies in the United States and internationally. It operates in two segments, Automotive and Medical. The company offers climate comfort systems, including seat heaters, blowers, and thermoelectric devices for variable temperature climate control seats and steering wheel heaters to provide thermal comfort to automobile passengers; integrated electronic components, such as electronic control units; pneumatic lumbar and massage comfort solutions comprising lumbar support, side bolster adjustment, multi-contour seats and massage systems; and other climate and comfort systems, including neck and shoulder conditioners, and climate control systems for door panels and armrests. It also provides automotive cable technology, such as ready-made individual cables and ready-to-install cable networks used to connect components to power sources; battery performance solutions consist of cell connecting devices and battery cable technologies used for various types of batteries and thermal management products; valve systems for brake and engine systems, and fuel management; and electronic and software systems include electronic control units for climate and comfort systems, and electronic control units for memory seat modules and other devices. In addition, the company offers patient temperature management systems under the Blanketrol/Kool-Kit/Maxi-Therm Lite, WarmAir/FilteredFlo, Astopad, Electri-Cool/Micro-Temp, Astotherm/Astoflo, and Hemotherm brands for hyper-hypothermia therapy in intensive care, normothermia in surgical procedures, and additional warming/cooling therapies. It serves light vehicle original equipment manufacturers and tier 1s, and medical industry. The company was formerly known as Amerigon Incorporated and changed its name to Gentherm Incorporated in September 2012. The company was incorporated in 1991 and is headquartered in Northville, Michigan.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Gentherm Inc (top by weight)
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Gentherm Inc data using free add-ons & libraries
Get Gentherm Inc Fundamental Data
Gentherm Inc Fundamental data includes:
- Net Revenue: 1 453 M
- EBITDA: 164 M
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-07-29
- EPS/Forecast: 0.572
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Gentherm Inc News

Are Investors Undervaluing Gentherm (THRM) Right Now?
While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With thi...


Therma Bright Proposes to Amend Certain Warrants
Toronto, Ontario--(Newsfile Corp. - August 28, 2025) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX0) ("Therma Bright" or the "Company") announces that subject to the approval of the TSX V...

Is Gentherm (THRM) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest...

Peptide Synthesis Company Evaluation Report 2025 | Thermo Fisher Scientific, Merck KGaA, and Agilent Technologies Lead with Advanced Instruments, Reagents, and Strategic Expansions
Dublin, Aug. 14, 2025 (GLOBE NEWSWIRE) -- The "Peptide Synthesis Company Evaluation Report" report has been added to ResearchAndMarkets.com's offering. The Peptide Synthesis Market Companies Qua...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.